PMGC Holdings Inc. Common Stock logo

ELAB Q2 2026 Earnings Results — PMGC Holdings Inc. Common Stock

XNAS · Healthcare · Biotechnology

Updated

Price $2.64
Market Cap $2.1M
P/E —
52W Range $2.52 – $1538.40

When is ELAB's next earnings date?

PMGC Holdings Inc. Common Stock (ELAB) has not announced its next earnings date yet. Its most recent earnings report was on Friday, August 14, 2026.

How did ELAB do in its last earnings report?

In its most recent report on Aug 14, 2026 (Q2 2026), PMGC Holdings Inc. Common Stock posted EPS of -$6.07. Revenue was $1.3M. The stock's 1-day post-earnings move was +1.5%.

How much does ELAB stock move after earnings?

Over the last 8 reports the stock moved an average of 3.1% (up or down) in the day after earnings.

About PMGC Holdings Inc. Common Stock

PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-14Q2 2026—-6.07—$1.3M—+1.49%-31.97%-48.47%
2026-05-15Q4 2025—-11.22—$681,994—+0.97%-19.42%-29.13%
2026-05-15Q1 2026—-11.22—$681,994—+0.97%-19.42%-29.13%
2025-11-14Q3 2025—-4.95—$285,948—-3.81%-13.43%-39.93%
2025-08-13Q2 2025—-0.47—$0—+2.07%+2.59%-29.24%
2024-11-14Q3 2024—-95.20—$527,478—+6.07%-13.36%-53.64%
2024-08-14Q2 2024—-112.00—$605,529—-6.60%-25.04%-7.05%
2024-05-15Q1 2024—-113.40—$614,563—+3.19%+5.56%-6.60%

Showing last 8 quarters.

Revenue by segment & region

By region

FY2023 · $2.2M total · annual

SegmentShareRevenueYoY
UNITED STATES78.7%$1.7M—
AUSTRIA10.8%$235K—
CANADA7.3%$159K—
VIET NAM3.2%$71K—

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .